Monitoring levels of asparagine and anti-L-asparaginase antibody in plasma of children with acute lymphoblastic leukemia.

被引：0
|
作者：
Jiang, H [1 ]
Gu, LJ [1 ]
Ye, H [1 ]
Tang, JY [1 ]
Xue, HL [1 ]
Chen, J [1 ]
Dong, L [1 ]
机构：
[1] Shanghai Med Univ 2, Shanghai Childrens Med Ctr, Xinhua Hosp, Dept Hematol Oncol, Shanghai, Peoples R China
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4559
引用
收藏
页码：210B / 210B
页数：1
相关论文
共 50 条
  • [1] Implications of IgG and IgE anti-L-asparaginase antibodies in children with acute lymphoblastic leukemia
    Galindo, G.
    Gonzalez, S.
    Cavazos, R.
    Heredia, A.
    Salinas, M.
    Trevino, H.
    ALLERGY, 2010, 65 : 694 - 694
  • [2] Monitoring of Anti-l-Asparaginase Antibody and l-Asparaginase Activity Levels in a Pediatric Patient With Acute Lymphoblastic Leukemia and Hypersensitivity to Native Escherichia coli l-Asparaginase During Desensitization Courses
    Kawahara, Yuta
    Morimoto, Akira
    Hayase, Tomomi
    Kashii, Yoshifumi
    Fukuda, Tokiko
    Momoi, Mariko Y.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (02) : E91 - E93
  • [3] L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment
    Tsurusawa, M
    Chin, M
    Iwai, A
    Nomura, K
    Maeba, H
    Taga, T
    Higa, T
    Kuno, T
    Hori, T
    Muto, A
    Yamagata, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (03) : 204 - 208
  • [4] l-Asparagine depletion levels and l-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment
    Masahito Tsurusawa
    Motoaki Chin
    Asayuki Iwai
    Keiko Nomura
    Hideaki Maeba
    Takashi Taga
    Takeshi Higa
    Tomoko Kuno
    Toshinori Hori
    Akiko Muto
    Miyo Yamagata
    Cancer Chemotherapy and Pharmacology, 2004, 53 : 204 - 208
  • [5] Monitoring of asparagine depletion and anti-l-asparaginase antibodies in adult acute lymphoblastic leukemia treated in the pediatric-inspired GRAALL-2005 trial
    Jérôme Paillassa
    Thibaut Leguay
    Xavier Thomas
    Françoise Huguet
    Marie Audrain
    Véronique Lheritier
    Christine Vianey-Saban
    Cécile Acquaviva-Bourdain
    Cécile Pagan
    Hervé Dombret
    Norbert Ifrah
    Nicolas Boissel
    Mathilde Hunault-Berger
    Blood Cancer Journal, 8
  • [6] Monitoring of asparagine depletion and anti-L-asparaginase antibodies in adult acute lymphoblastic leukemia treated in the pediatric-inspired GRAALL-2005 trial
    Paillassa, Jerome
    Leguay, Thibaut
    Thomas, Xavier
    Huguet, Francoise
    Audrain, Marie
    Lheritier, Veronique
    Vianey-Saban, Christine
    Acquaviva-Bourdain, Cecile
    Pagan, Cecile
    Dombret, Herve
    Ifrah, Norbert
    Boissel, Nicolas
    Hunault-Berger, Mathilde
    BLOOD CANCER JOURNAL, 2018, 8
  • [7] Highly-sensitive assay of L-asparaginase activity can accurately estimate the asparagine depletion levels in plasma of children with acute lymphoblastic leukemia.
    Tsurusawa, M
    Hori, T
    Iwai, A
    Nomura, K
    Maeba, H
    Taga, T
    Higa, T
    Mutou, A
    Kuno, T
    Chin, M
    Yamagata, M
    BLOOD, 2003, 102 (11) : 230B - 230B
  • [8] Dynamic changes in specific anti-L-asparaginase antibodies generation during acute lymphoblastic leukemia treatment
    Walenciak, Justyna
    Wyka, Krystyna
    Janczar, Szymon
    Mlynarski, Wojciech
    Zalewska-Szewczyk, Beata
    PHARMACOLOGICAL REPORTS, 2019, 71 (02) : 311 - 318
  • [9] Dynamic changes in specific anti-L-asparaginase antibodies generation during acute lymphoblastic leukemia treatment
    Justyna Walenciak
    Krystyna Wyka
    Szymon Janczar
    Wojciech Młynarski
    Beata Zalewska-Szewczyk
    Pharmacological Reports, 2019, 71 : 311 - 318
  • [10] L-asparaginase activity and anti-L-asparaginase antibody as biomarkers in estimating PEG-asp-related anaphylaxis risk in childhood acute lymphoblastic leukemia patients
    Cui, Jiali
    Jiang, Lian
    Xu, Bei
    Bai, Yajie
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2023, 51 (03) : 28 - 35
12345